CCR2 and neoplasm: Kynurenine produced by glioblastoma cells can activate aryl hydrocarbon receptors and upregulate the expression of CCR2 and CD39 on macrophages, thereby increasing adenosine levels and suppressing tumor-specific T cell response (171).